This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignees: Laboratorios Salvat, S.a., Chiesi Farmaceutici S.p.a.. Active years: 2005-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2008
Title: Innovations of Ignacio José Miquel Bono
Introduction
Ignacio José Miquel Bono is a notable inventor based in L'Hospitalet de Llobregat, Spain. He has made significant contributions to the field of pharmacology, particularly in the development of muscarinic receptor antagonists. With a total of 3 patents to his name, Bono's work has the potential to impact various medical treatments.
Latest Patents
Bono's latest patents include innovative compounds such as 1-alkyl-1-azoniabicyclo[2.2.2]octane carbamate derivatives. These compounds are designed for use as muscarinic receptor antagonists, which can be beneficial in treating conditions like urinary incontinence, irritable bowel syndrome, and respiratory disorders. The carbamate of general formula (I) showcases a variety of substituents that enhance its therapeutic efficacy. Another significant patent involves carbamates derived from arylalkylamines, which also target the Mmuscarinic receptor, offering potential treatments for similar medical conditions.
Career Highlights
Throughout his career, Ignacio José Miquel Bono has worked with reputable companies such as Laboratorios Salvat and Chiesi Farmaceutici. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Bono has collaborated with notable colleagues, including Carles Farrerons Gallemi and Juan Lorenzo Catena Ruiz. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Ignacio José Miquel Bono's contributions to pharmacology through his innovative patents highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
